GO Term | Evidence Code | PMID |
---|---|---|
negative regulation of fatty acid metabolic process | ||
xenobiotic metabolic process | ||
negative regulation of cellular glucuronidation | ||
flavonoid glucuronidation | ||
negative regulation of glucuronosyltransferase activity |
|
GO Term | Evidence Code | PMID |
---|---|---|
endoplasmic reticulum | ||
plasma membrane | ||
cytochrome complex | ||
endoplasmic reticulum chaperone complex | ||
endoplasmic reticulum membrane |
GO Term | Evidence Code | PMID |
---|---|---|
enzyme binding | ||
steroid binding | ||
protein homodimerization activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:10211 | cholelithiasis | |
DOID:11151 | cholecystolithiasis | |
DOID:1380 | endometrial cancer | |
DOID:1612 | breast cancer | |
DOID:2043 | hepatitis B | |
DOID:2394 | ovarian cancer | |
DOID:2739 | Gilbert syndrome | |
DOID:2741 | bilirubin metabolic disorder | |
DOID:3803 | Crigler-Najjar syndrome | |
DOID:3908 | lung non-small cell carcinoma |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000365 | Hearing impairment |
HP:0000750 | Delayed speech and language development |
HP:0000952 | Jaundice |
HP:0001080 | Biliary tract abnormality |
HP:0001249 | Intellectual disability |
HP:0001250 | Seizure |
HP:0001298 | Encephalopathy |
HP:0001337 | Tremor |
HP:0001343 | Kernicterus |
Disease ID | Disease Name |
---|---|
OMIM:218800 |
|
OMIM:143500 |
|
OMIM:606785 |
|
OMIM:237900 |
|
ORPHA:79235 |
|
ORPHA:79234 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025